[논문]말초 아밀로이드 베타 원천으로서의 혈소판과 알츠하이머병의 혈액 바이오마커로서의 가능성

강재선; 최윤식

doi:10.5352/jls.2020.30.12.1118

말초 아밀로이드 베타 원천으로서의 혈소판과 알츠하이머병의 혈액 바이오마커로서의 가능성
Platelets as a Source of Peripheral Aβ Production and Its Potential as a Blood-based Biomarker for Alzheimer's Disease 원문보기

생명과학회지 = Journal of life science, v.30 no.12, 2020년, pp.1118 - 1127

강재선 (경성대학교 약학과) , 최윤식 (경성대학교 약학과)

초록
AI-Helper

알츠하이머병은 점진적인 신경세포의 손상과 이로 인해 인지기능 장애를 유발하는 질병이다. 이 질환은 현재로서는 치료할 수 있는 질환이 아니고 진행을 멈추게 할 수 있는 방법이 없다. 그러나 초기에 알츠하이머병을 치료하는 것이 가장 효과적이므로 초기 진단은 증상을 관리할 수 있는 가장 좋은 기회를 제공할 수 있다. 알츠하이머병을 진단하기 위한 바이오마커로는 아밀로이드 베타(Aβ), 병적인 타우, 그리고 신경퇴화가 있고, Aβ의 축적, 인산화 타우는 뇌척수액이나 양전자 방출 단층촬영술을 통해 분석할 수 있다. 그러나 뇌척수액의 채취는 매우 침습적이고 양전자 방출 단층촬영술은 전문적인 고가의 장비가 필요하다. 지난 수십년 동안 빠르고 최소한의 침습성을 가진 바이오마커 분석법을 개발하기 위하여 혈액에 기반한 바이오마커 분석 기술이 연구되어 왔다. 그 중 주목할 만 한 발견이 혈장에서 Aβ의 주요 원천으로 혈소판과의 관련성이다. 아밀로이드 베타는 혈액-뇌 장벽을 통과 할 수 있고 정상 상태에서는 뇌와 혈액 간 평형을 이루게 된다. 흥미롭게도, 여러 임상시험 결과 혈장에서 Aβ42/Aβ40 비율이 가벼운 인지장애 질환과 알츠하이머병에서 감소되어 있는 것을 증명하였다. 종합하면, 이러한 최근의 발견들은 침습성을 최소화한 알츠하이머병의 초기 진단 기술을 개발하는 데 이용될 수 있다. 본 총설에서, 저자들은 알츠하이머병의 바이오마커에 대한 최근 연구결과들, 특히 말초에서 Aβ를 생산하는 혈소판의 역할과 혈액 기반 바이오마커로서의 개발 가능성에 대해 고찰하였다.

Abstract ▼ AI-Helper

Alzheimer's disease causes progressive neuronal loss that leads to cognitive disturbances. It is not currently curable, and there is no way to stop its progression. However, since medical treatment for Alzheimer's disease is most effective in the early stages, early detection can provide the best chance for symptom management. Biomarkers for the diagnosis of Alzheimer's disease include amyloid β (Aβ) deposition, pathologic tau, and neurodegeneration. Aβ deposition and phosphorylated tau can be detected by cerebrospinal fluid (CSF) analysis or positron emission tomography (PET). However, CSF sampling is quite invasive, and PET analysis needs specialized and expensive equipment. During the last decades, blood-based biomarker analysis has been studied to develop fast and minimally invasive biomarker analysis method. And one of the remarkable findings is the involvement of platelets as a primary source of Aβ in plasma. Aβ can be transported across the blood - brain barrier, creating an equilibrium of Aβ levels between the brain and blood under normal condition. Interestingly, a number of clinical studies have unequivocally demonstrated that plasma Aβ42/Aβ40 ratios are reduced in mild cognitive impairment and Alzheimer's disease. Together, these recent findings may lead to the development of a fast and minimally invasive early diagnostic approach to Alzheimer's disease. In this review, we summarize recent advances in the biomarkers of Alzheimer's disease, especially the involvement of platelets as a source of peripheral Aβ production and its potential as a blood-based biomarker.

주제어

표/그림 (2)

그림 Fig. 1. Amyloid precursor protein (APP) processing pathways.
그림 Fig. 2. Plasma Aβ level is increased in certain conditions such as mild cognitive impairment, Alzheimer's disease or increased membrane cholesterol con-tent in platelets. These events may disrupt the balance of Aβ concentration between brain and plasma, and lead increased influx of Aβ peptides into the brain resulting in Aβ plaque formation. RAGE: receptors for advanced glycation end products, LRP: LDL receptor-related proteins, A β: amyloid β, BBB: blood-brain barrier.

AI 본문요약
AI-Helper

성능/효과

Sampling of CSF is an invasive procedure, and PET analysis needs expensive equipment. Therefore, a fast, non-invasive, and cost-saving biomarker analysis method is needed, and a validated blood- based biomarker analysis could be the answer.

참고문헌 (74)

Abdullah, L., Luis, C., Paris, D., Mouzon, B., Ait-Ghezala, G., Keegan, A. P., Wang, D., Crawford, F. and Mullan, M. 2009. Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT sub-cohort. Mol. Med. 15, 432-437.

상세보기
Attems, J., Lintner, F. and Jellinger, K. A. 2004. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol. 107, 283-291.

상세보기
Bermejo-Bescos, P., Martin-Aragon, S., Jimenez-Aliaga, K., Benedi, J., Felici, E., Gil, P., Ribera, J. M. and Villar, A. M. 2013. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI). Neurochem. Res. 38, 1415-1423.

상세보기
Biino, G., Gasparini, P., D'Adamo, P., Ciullo, M., Nutile, T., Toniolo, D., Sala, C., Minelli, C., Gogele, M. and Balduini, C, L. 2012. Influence of age, sex and ethnicity on platelet count in five Italian geographic isolates: mild thrombocytopenia may be physiological. Br. J. Haematol. 157, 384-387.

상세보기
Biino, G., Santimone, I., Minelli, C., Sorice, R., Frongia, B., Traglia, M., Ulivi, S., Di Castelnuovo, A., Gogele, M., Nutile, T., Francavilla, M., Sala, C., Pirastu, N., Cerletti, C., Iacoviello, L., Gasparini, P., Toniolo, D., Ciullo, M., Pramstaller, P., Pirastu, M., de Gaetano, G. and Balduini, C. L. 2013. Ageand sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PLoS One 8, e54289.

상세보기
Blennow, K., De Meyer, G., Hansson, O., Minthon, L., Wallin, A., Zetterberg, H., Lewczuk, P., Vanderstichele, H., Vanmechelen, E., Kornhuber, J., Wiltfang, J.; KND-Study Group, Heuser, I., Maier, W., Luckhaus, C., Ruther, E., Hull, M., Jahn, H., Gertz, H. J., Frolich, L., Hampel, H. and Pernetzki, R. 2009. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J. Nutr. Health Aging 13, 205-208.

상세보기
Bu, X. L., Xiang, Y., Jin, W. S., Wang, J., Shen, L. L., Huang, Z. L., Zhang, K., Liu, Y. H., Zeng, F., Liu, J. H., Sun, H. L., Zhuang, Z. Q., Chen, S. H., Yao, X. Q., Giunta, B., Shan, Y. C., Tan, J., Chen, X. W., Dong, Z. F., Zhou, H. D., Zhou, X. F., Song, W. and Wang, Y. J. 2018. Blood-derived amyloid-β protein induces Alzheimer's disease pathologies. Mol. Psychiatry 23, 1948-1956.

상세보기
Bulbarelli, A., Lonati, E., Brambilla, A., Orlando, A., Cazzaniga, E., Piazza, F., Ferrarese, C., Masserini, M. and Sancini, G. 2012. Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol. Cell Neurosci. 49, 415-422.

상세보기
Buniatian, G. H., Hartmann, H. J., Traub, P., Wiesinger, H., Albinus, M., Nagel, W., Shoeman, R., Mecke, D. and Weser, U. 2002. Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes. Anat. Rec. 267, 296-306.

상세보기
Chao, A. C., Lee, T. C., Juo, S. H. and Yang, D. I. 2016. Hyperglycemia increases the production of amyloid beta-peptide leading to decreased endothelial tight junction. CNS Neurosci. Ther. 22, 291-297

상세보기
Chen, S. H., Bu, X. L., Jin, W. S., Shen, L. L., Wang, J., Zhuang, Z. Q., Zhang, T., Zeng, F., Yao, X. Q., Zhou, H. D. and Wang, Y. J. 2017. Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study. Medicine (Baltimore) 96, e6843.

상세보기
Chen, M., Inestrosa, N. C., Ross, G. S. and Fernandez, H. L. 1995. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 213, 96-103.

상세보기
Chen, G. F., Xu, T. H., Yan, Y., Zhou, Y. R., Jiang, Y., Melcher, K. and Xu, H. E. 2017. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205-1235.

상세보기
Cheng, Y., Tian, D. Y. and Wang, Y. J. 2020. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives. Transl. Neurodegener. 9, 16.

상세보기
Chouraki, V., Beiser, A., Younkin, L., Preis, S. R., Weinstein, G., Hansson, O., Skoog, I., Lambert, J. C., Au, R., Launer, L., Wolf, P. A., Younkin, S. and Seshadri, S. 2015. Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study. Alzheimers Dement. 11, 249-257.

상세보기
Colciaghi, F., Borroni, B., Pastorino, L., Marcello, E., Zimmermann, M., Cattabeni, F., Padovani, A. and Di Luca, M. 2002. α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8, 67-74.

상세보기
Davies, T. A., Billingslea, A. M., Long, H. J., Tibbles, H., Wells, J. M., Eisenhauer, P. B., Smith, S. J., Cribbs, D. H., Fine, R. E. and Simons, E. R. 1998. Brain endothelial cell enzymes cleave platelet-retained amyloid precursor protein. J. Lab. Clin. Med. 132, 341-350.

상세보기
Davies, T. A., Long, H. J., Sgro, K., Rathbun, W. H., Mc Menamin, M. E., Seetoo, K., Tibbles, H., Billingslea, A. M., Fine, R. E., Fishman, J. B., Levesque, C. A., Smith, S. J., Wells, J. M. and Simons, E. R. 1997. Activated Alzheimer disease platelets retain more beta amyloid precursor protein. Neurobiol. Aging 18, 147-153.

상세보기
Deane, R., Bell, R. D., Sagare, A. and Zlokovic, B. V. 2009. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 8, 16-30.

상세보기
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., Zhu, H., Ghiso, J., Frangione, B., Stern, A., Schmidt, A. M., Armstrong, D. L., Arnold, B., Liliensiek, B., Nawroth, P., Hofman, F., Kindy, M., Stern, D. and Zlokovic, B. 2003. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907-913.

상세보기
DeKosky, S. T. and Marek, K. 2003. Looking backward to move forward: early detection of neurodegenerative disorders. Science 302, 830-834.

상세보기
DeMattos, R. B., Bales, K. R., Parsadanian, M., O'Dell, M. A., Foss, E. M., Paul, S. M. and Holtzman, D. M. 2002. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J. Neurochem. 81, 229-236.

상세보기
Do, T. M., Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. M., Farinotti, R. and Bourasset, F. 2016. Age-dependent regulation of the blood-brain barrier influx/efflux equilibrium of amyloid-β peptide in a mouse model of Alzheimer's disease (3xTg-AD). J. Alzheimers Dis. 49, 287-300.
Dong, X., Nao, J., Shi, J. and Zheng, D. 2019. Predictive value of routine peripheral blood biomarkers in Alzheimer's disease. Front. Aging Neurosci. 11, 332.

상세보기
d'Uscio, L. V., He, T. and Katusic, Z. S. 2017. Expression and processing of amyloid precursor protein in vascular endothelium. Physiology (Bethesda) 32, 20-32.
d'Uscio, L. V. and Katusic, Z. S. 2019. Vascular phenotype of amyloid precursor protein-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 316, H1297-H1308.

상세보기
Evin, G. and Li, Q. X. 2012. Platelets and Alzheimer's disease: Potential of APP as a biomarker. World J. Psychiatry 2, 102-113.

상세보기
Evin, G., Zhu, A., Holsinger, R. M., Masters, C. L. and Li, Q. X. 2003. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. J. Neurosci. Res. 74, 386-392.

상세보기
Fandos, N., Perez-Grijalba, V., Pesini, P., Olmos, S., Bossa, M., Villemagne, V. L., Doecke, J., Fowler, C., Masters, C. L. and Sarasa, M. AIBL Research Group. 2017. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst). 8, 179-187.

상세보기
Gowert, N. S., Donner, L., Chatterjee, M., Eisele, Y. S., Towhid, S. T., Munzer, P., Walker, B., Ogorek, I., Borst, O., Grandoch, M., Schaller, M., Fischer, J. W., Gawaz, M., Weggen, S., Lang, F., Jucker, M. and Elvers, M. 2014. Blood platelets in the progression of Alzheimer's disease. PLoS One 9, e90523.

상세보기
Graff-Radford, N. R., Crook, J. E., Lucas, J., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C. and Younkin, S. G. 2007. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch. Neurol. 64, 354-362.

상세보기
Guest, F. L., Rahmoune, H. and Guest, P. C. 2020. Early diagnosis and targeted treatment strategy for improved therapeutic outcomes in Alzheimer's disease. Adv. Exp. Med. Biol. 1260, 175-191.
Hampel, H., O'Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R. and Blennow, K. 2018. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat. Rev. Neurol. 14, 639-652.

상세보기
Inyushin, M. Y., Sanabria, P., Rojas, L., Kucheryavykh, Y. and Kucheryavykh, L. 2017. Aβ peptide originated from platelets promises new strategy in anti-Alzheimer's drug development. Biomed. Res. Int. 2017, 3948360.
Jack, C. R. Jr, Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M. and Sperling, R. 2018. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 14, 535-562.

상세보기
Kelley, M., Ulin, B. and McGuire, L. C. 2018. Reducing the risk of Alzheimer's disease and maintaining brain health in an aging society. Public Health Rep. 133, 225-229.

상세보기
Kim, H. J., Park, K. W., Kim, T. E., Im, J. Y., Shin, H. S., Kim, S., Lee, D. H., Ye, B. S., Kim, J. H., Kim, E. J., Park, K. H., Han, H. J., Jeong, J. H., Choi, S. H. and Park, S. A. 2015. Elevation of the plasma Aβ40/Aβ42 ratio as a diagnostic marker of sporadic early-onset Alzheimer's disease. J. Alzheimers Dis. 48, 1043-1050.

상세보기
Koc, E. R., Uzar, E., Cirak, Y., Parlak Demir, Y. and Ilhan, A. 2014. The increase of mean platelet volume in patients with Alzheimer disease. Turk. J. Med. Sci. 44, 1060-1066.

상세보기
Korniluk, A., Koper-Lenkiewicz, O. M., Kaminska, J., Kemona, H. and Dymicka-Piekarska, V. 2019. Mean Platelet Volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019, 9213074.

상세보기
Koyama, A., Okereke, O. I., Yang, T., Blacker, D., Selkoe, D. J. and Grodstein, F. 2012. Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch. Neurol. 69, 824-831.
Kukull, W. A. and Bowen, J. D. 2002. Dementia epidemiology. Med. Clin. North Am. 86, 573-590.

상세보기
Lambert, J. C., Schraen-Maschke, S., Richard, F., Fievet, N., Rouaud, O., Berr, C., Dartigues, J. F., Tzourio, C., Alperovitch, A., Buee, L. and Amouyel, P. 2009. Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 73, 847-853.

상세보기
Lewczuk, P. and Kornhuber, J. 2016. Do we still need positron emission tomography for early Alzheimer's disease diagnosis- Brain 139, e60.

상세보기
Li, R., Hoffmeister, K. M. and Falet, H. 2016. Glycans and the platelet life cycle. Platelets 27, 505-511.

상세보기
Li, Q. X., Whyte, S., Tanner, J. E., Evin, G., Beyreuther, K. and Masters, C. L. 1998. Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Lab. Invest. 78, 461-469.
Liang, Q. C., Jin, D., Li, Y. and Wang, R. T. 2014. Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease. Platelets 25, 433-438.

상세보기
Liu, W. W., Todd, S., Coulson, D. T., Irvine, G. B., Passmore, A. P., McGuinness, B., McConville, M., Craig, D. and Johnston, J. A. 2009. A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets. J. Neurochem. 108, 341-249.

상세보기
Liu, W. W., Todd, S., Craig, D., Passmore, A. P., Coulson, D. T., Murphy, S., Irvine, G. B. and Johnston, J. A. 2007. Elevated platelet beta-secretase activity in mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 24, 464-468.

상세보기
Mantzavinos, V. and Alexiou, A. 2017. Biomarkers for Alzheimer's disease diagnosis. Curr. Alzheimer Res. 14, 1149- 1154.
McGuinness, B., Fuchs, M., Barrett, S. L., Passmore, A. P. and Johnston, J. A. 2016. Platelet membrane β-secretase activity in mild cognitive impairment and conversion to dementia: a longitudinal study. J. Alzheimers Dis. 49, 1095-1103.
Muche, A., Burger, S., Arendt, T. and Schliebs, R. 2015. Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study. Nutr. Neurosci. 18, 1-11.

상세보기
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Dore, V., Fowler, C., Li, Q. X., Martins, R., Rowe, C., Tomita, T., Matsuzaki, K., Ishii, K., Ishii, K., Arahata, Y., Iwamoto, S., Ito, K., Tanaka, K., Masters, C. L. and Yanagisawa, K. 2018. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature 554, 249-254.

상세보기
Nayak, M. K., Kulkarni, P. P. and Dash, D. 2013. Regulatory role of proteasome in determination of platelet life span. J. Biol. Chem. 288, 6826-6834.

상세보기
Nguyen, K. V. 2018. Special Issue: Alzheimer's disease. AIMS Neurosci. 5, 74-80.

상세보기
Okereke, O. I., Xia, W., Selkoe, D. J. and Grodstein, F. 2009. Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch. Neurol. 66, 1247-1253.

상세보기
Ovod, V., Ramsey, K. N., Mawuenyega, K. G., Bollinger, J. G., Hicks, T., Schneider, T., Sullivan, M., Paumier, K., Holtzman, D. M., Morris, J. C., Benzinger, T., Fagan, A. M., Patterson, B. W. and Bateman, R. J. 2017. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement. 13, 841-849.

상세보기
Perez-Grijalba, V., Romero, J., Pesini, P., Sarasa, L., Monleon, I., San-Jose, I., Arbizu, J., Martinez-Lage, P., Munuera, J., Ruiz, A., Tarraga, L., Boada, M. and Sarasa, M. 2019. Plasma Aβ42/40 ratio detects early stages of Alzheimer's disease and correlates with CSF and neuroimaging biomarkers in the AB255 study. J. Prev. Alzheimers Dis. 6, 34-41.
Roher, A. E., Esh, C. L., Kokjohn, T. A., Castano, E. M., Van Vickle, G. D., Kalback, W. M., Patton, R. L., Luehrs, D. C., Daugs, I. D., Kuo, Y. M., Emmerling, M. R., Soares, H., Quinn, J. F., Kaye, J., Connor, D. J., Silverberg, N. B., Adler, C. H., Seward, J. D., Beach, T. G. and Sabbagh, M. N. 2009. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement. 5, 18-29.

상세보기
Santimone, I., Di Castelnuovo, A., De Curtis, A., Spinelli, M., Cugino, D., Gianfagna, F., Zito, F., Donati, M. B., Cerletti, C., de Gaetano, G., Iacoviello, L. and MOLI-SANI Project Investigators. 2011. White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica 96, 1180-1188.

상세보기
Schupf, N., Tang, M. X., Fukuyama, H., Manly, J., Andrews, H., Mehta, P., Ravetch, J. and Mayeux, R. 2008. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 105, 14052-14057.

상세보기
Segal, J. B. and Moliterno, A. R. 2006. Platelet counts differ by sex, ethnicity, and age in the United States. Ann. Epidemiol. 16, 123-130.

상세보기
Seppala, T. T., Nerg, O., Koivisto, A. M., Rummukainen, J., Puli, L., Zetterberg, H., Pyykko, O. T., Helisalmi, S., Alafuzoff, I., Hiltunen, M., Jaaskelainen, J. E., Rinne, J., Soininen, H., Leinonen, V. and Herukka, S. K. 2012. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78, 1568-1575.

상세보기
Sevush, S., Jy, W., Horstman, L. L., Mao, W. W., Kolodny, L. and Ahn, Y. S. 1998. Platelet activation in Alzheimer disease. Arch. Neurol. 55, 530-536.

상세보기
Shahpasand-Kroner, H., Klafki, H. W., Bauer, C., Schuchhardt, J., Huttenrauch, M., Stazi, M., Bouter, C., Wirths, O., Vogelgsang, J. and Wiltfang, J. 2018. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease. Alzheimers Res. Ther. 10, 121.

상세보기
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J. and Zlokovic, B. V. 2000. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499.

상세보기
Sonkar, V. K., Kulkarni, P. P. and Dash, D. 2014. Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization. FASEB J. 28, 1819-1829.

상세보기
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S. and Stellos, K. 2020. The Alzheimer's Disease Amyloid-beta hypothesis in cardiovascular aging and disease: JACC Focus Seminar. J. Am. Coll. Cardiol. 75, 952-967.

상세보기
Stevens, R. F. and Alexander, M. K. 1977. A sex difference in the platelet count. Br. J. Haematol. 37, 295-300.

상세보기
Tang, K., Hynan, L. S., Baskin, F. and Rosenberg, R. N. 2006. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J. Neurol. Sci. 240, 53-58.

상세보기
Van Nostrand, W. E., Schmaier, A. H., Farrow, J. S. and Cunningham, D. D. 1990. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 248, 745-748.

상세보기
Wang, H., Chen, F., Du, Y. F., Long, Y., Reed, M. N., Hu, M., Suppiramaniam, V., Hong, H. and Tang, S. S. 2018. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice. Neuropharmacology 131, 143-153.

상세보기
Wang, R. T., Jin, D., Li, Y. and Liang, Q. C. 2013. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease. J. Psychiatr. Res. 47, 644-649.

상세보기
Weller, J. and Budson, A. 2018. Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res. 7, 1161.

상세보기
Wolk, D. A., Grachev, I. D., Buckley, C., Kazi, H., Grady, M. S., Trojanowski, J. Q., Hamilton, R. H., Sherwin, P., McLain, R. and Arnold, S. E. 2011. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Arch. Neurol. 68, 1398-1403.

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증